Found: 19
Select item for more details and to access through your institution.
Comparison of specialized stent versus generic stent and bare stent combination for transjugular intrahepatic portosystemic shunt creation.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-64358-0
- By:
- Publication type:
- Article
Activation of AMPK pathway by low‑dose donafenib and atorvastatin combination improves high‑fat diet‑induced metabolic dysfunction‑associated steatotic liver disease.
- Published in:
- Molecular Medicine Reports, 2024, v. 29, n. 3, p. N.PAG, doi. 10.3892/mmr.2024.13175
- By:
- Publication type:
- Article
Ginkgetin exhibits antifibrotic effects by inducing hepatic stellate cell apoptosis via STAT1 activation.
- Published in:
- Phytotherapy Research, 2024, v. 38, n. 3, p. 1367, doi. 10.1002/ptr.8106
- By:
- Publication type:
- Article
Synergistic Effects of Nanoscale CaO<sub>2</sub> Combined with PD-1 Inhibitors in the Treatment of Hepatocellular Carcinoma: A Promising Combination.
- Published in:
- International Journal of Nanomedicine, 2024, v. 19, p. 137, doi. 10.2147/IJN.S440387
- By:
- Publication type:
- Article
Reversion of liver cirrhosis after endovascular treatment in Chinese patients with Budd–Chiari syndrome.
- Published in:
- Hepatology Research, 2023, v. 53, n. 12, p. 1198, doi. 10.1111/hepr.13960
- By:
- Publication type:
- Article
Beneficial effects of ginkgetin on improving nonalcoholic steatohepatitis characterized by bulk and single-cell RNA sequencing analysis.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1267445
- By:
- Publication type:
- Article
Aerobic exercise and vitamin E improve high-fat diet-induced NAFLD in rats by regulating the AMPK pathway and oxidative stress.
- Published in:
- European Journal of Nutrition, 2023, v. 62, n. 6, p. 2621, doi. 10.1007/s00394-023-03179-9
- By:
- Publication type:
- Article
Mild Prolongation of Prothrombin Time Does Not Affect the Safety and Prognosis of Transjugular Intrahepatic Portal Shunt: Based on Real-World Data.
- Published in:
- Turkish Journal of Gastroenterology, 2023, v. 34, n. 8, p. 873, doi. 10.5152/tjg.2023.22410
- By:
- Publication type:
- Article
Sarcopenia Defined by Psoas Muscle Thickness Predicts Mortality After Transjugular Intrahepatic Portosystemic Shunt.
- Published in:
- Digestive Diseases & Sciences, 2023, v. 68, n. 4, p. 1641, doi. 10.1007/s10620-022-07806-z
- By:
- Publication type:
- Article
The impact of thrombocytopenia on variceal bleeding in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-28646-5
- By:
- Publication type:
- Article
A VEGFR targeting peptide-drug conjugate (PDC) suppresses tumor angiogenesis in a TACE model for hepatocellular carcinoma therapy.
- Published in:
- Cell Death Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41420-022-01198-9
- By:
- Publication type:
- Article
Natural History and Influence on Long-term Outcomes of Isolated Type II Endoleak after Endovascular Aneurysm Repair: A 10-year Experience at a Single Center.
- Published in:
- Reviews in Cardiovascular Medicine, 2022, v. 23, n. 3, p. 1, doi. 10.31083/j.rcm2303099
- By:
- Publication type:
- Article
Portal flow diversion based on portography is superior than puncture site in the prediction of overt hepatic encephalopathy after TIPS creation.
- Published in:
- BMC Gastroenterology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12876-022-02447-y
- By:
- Publication type:
- Article
Transjugular intrahepatic portosystemic shunt in patients with autoimmune hepatitis-induced cirrhosis and variceal bleeding.
- Published in:
- Abdominal Radiology, 2022, v. 47, n. 4, p. 1464, doi. 10.1007/s00261-022-03465-w
- By:
- Publication type:
- Article
Late combination of transarterial chemoembolization with apatinib and camrelizumab for unresectable hepatocellular carcinoma is superior to early combination.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Apatinib Plus Camrelizumab With/Without Chemoembolization for Hepatocellular Carcinoma: A Real-World Experience of a Single Center.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2021.835889
- By:
- Publication type:
- Article
Comparison of Treatment Response, Survival Profiles, as Well as Safety Profiles Between CalliSpheres<sup>®</sup> Microsphere Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Huge Hepatocellular Carcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.793581
- By:
- Publication type:
- Article
PSMC2/ITGA6 axis plays critical role in the development and progression of hepatocellular carcinoma.
- Published in:
- Cell Death Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41420-021-00585-y
- By:
- Publication type:
- Article
Arsenic trioxide-loaded CalliSpheres: In vitro study of drug release and antitumor activity, and in vivo study of pharmacokinetics, treatment efficacy and safety in liver cancer.
- Published in:
- Oncology Reports, 2021, v. 46, n. 1, p. N.PAG, doi. 10.3892/or.2021.8075
- By:
- Publication type:
- Article